Crumpacker CS - Search Results

1

Absence of antibodies to HTLV-III in health workers after hepatitis B vaccination.

Dienstag JL, Werner BG, McLane MF, Snydman DR, Grady GF, Craven DE, Crumpacker CS, Polk BF, Platt R, Allan J, et al. Dienstag JL, et al. Among authors: crumpacker cs. JAMA. 1985 Aug 23-30;254(8):1064-6. JAMA. 1985. PMID: 2991619

2

A multivariate analysis of risk factors for hepatitis B virus infection among hospital employees screened for vaccination.

Snydman DR, Muñoz A, Werner BG, Polk BF, Craven DE, Platt R, Crumpacker C, Ouellet-Hellstrom R, Nash B, Grady GF, et al. Snydman DR, et al. Am J Epidemiol. 1984 Nov;120(5):684-93. doi: 10.1093/oxfordjournals.aje.a113935. Am J Epidemiol. 1984. PMID: 6496449

3

Isolated antibody to hepatitis B surface antigen and response to hepatitis B vaccination.

Werner BG, Dienstag JL, Kuter BJ, Polk BF, Snydman DR, Craven DE, Crumpacker CS, Platt R, Grady GF. Werner BG, et al. Among authors: crumpacker cs. Ann Intern Med. 1985 Aug;103(2):201-5. doi: 10.7326/0003-4819-103-2-201. Ann Intern Med. 1985. PMID: 3160274

4

Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy.

Dienstag JL, Werner BG, Polk BF, Snydman DR, Craven DE, Platt R, Crumpacker CS, Ouellet-Hellstrom R, Grady GF. Dienstag JL, et al. Among authors: crumpacker cs. Ann Intern Med. 1984 Jul;101(1):34-40. doi: 10.7326/0003-4819-101-1-34. Ann Intern Med. 1984. PMID: 6233921 Clinical Trial.

5

Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings.

Craven DE, Awdeh ZL, Kunches LM, Yunis EJ, Dienstag JL, Werner BG, Polk BF, Syndman DR, Platt R, Crumpacker CS, et al. Craven DE, et al. Among authors: crumpacker cs. Ann Intern Med. 1986 Sep;105(3):356-60. doi: 10.7326/0003-4819-105-3-356. Ann Intern Med. 1986. PMID: 2943202

6

Ganciclovir for treatment of renal transplant-associated primary cytomegalovirus pneumonia.

Hecht DW, Snydman DR, Crumpacker CS, Werner BG, Heinze-Lacey B. Hecht DW, et al. Among authors: crumpacker cs. J Infect Dis. 1988 Jan;157(1):187-90. doi: 10.1093/infdis/157.1.187. J Infect Dis. 1988. PMID: 2826608 Clinical Trial. No abstract available.

7

Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation.

Crumpacker C, Heagy W, Bubley G, Monroe JE, Finberg R, Hussey S, Schnipper L, Lucey D, Lee TH, McLane MF, et al. Crumpacker C, et al. Ann Intern Med. 1987 Nov;107(5):664-74. doi: 10.7326/0003-4819-107-5-664. Ann Intern Med. 1987. PMID: 3662279

8

Detection of human cytomegalovirus DNA, RNA, and antibody in normal donor blood.

Zhang LJ, Hanff P, Rutherford C, Churchill WH, Crumpacker CS. Zhang LJ, et al. Among authors: crumpacker cs. J Infect Dis. 1995 Apr;171(4):1002-6. doi: 10.1093/infdis/171.4.1002. J Infect Dis. 1995. PMID: 7706776

9

Ganciclovir treatment of cytomegalovirus colitis in AIDS: a randomized, double-blind, placebo-controlled multicenter study.

Dieterich DT, Kotler DP, Busch DF, Crumpacker C, Du Mond C, Dearmand B, Buhles W. Dieterich DT, et al. J Infect Dis. 1993 Feb;167(2):278-82. doi: 10.1093/infdis/167.2.278. J Infect Dis. 1993. PMID: 8380610 Clinical Trial.

10

Inhibition of immune functions by antiviral drugs.

Heagy W, Crumpacker C, Lopez PA, Finberg RW. Heagy W, et al. J Clin Invest. 1991 Jun;87(6):1916-24. doi: 10.1172/JCI115217. J Clin Invest. 1991. PMID: 1904068 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters